default author photo

Rositsa Dimova

Acumen, LLC

500 Airport Blvd

# 365

Burlingame, CA 94010

United States

SCHOLARLY PAPERS

4

DOWNLOADS

227

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019–2020

Number of pages: 30 Posted: 08 Sep 2022
IBM Consulting, Acumen, LLC, IBM Consulting, U.S. Food and Drug Administration, Acumen, LLC, Acumen, LLC, IBM Consulting, Acumen, LLC, IBM Consulting, IBM Consulting, Acumen, LLC, IBM Consulting, Acumen, LLC, IBM Consulting, Gevity Inc, IBM Consulting, IBM Consulting, IBM Consulting, Centers for Medicare and Medicaid Services, IQVIA - Real World Solutions, Epidemiology, Optum, Aetna, Inc., Anthem Inc. - HealthCore, Epidemiology, Optum, IQVIA, Aetna, Inc., Epidemiology, Optum, U.S. Food and Drug Administration, Acumen, LLC, Acumen, LLC, Acumen, LLC, U.S. Food and Drug Administration, U.S. Food and Drug Administration, U.S. Food and Drug Administration, U.S. Food and Drug Administration and U.S. Food and Drug Administration
Downloads 73 (860,052)

Abstract:

Loading...

background rates, vaccine safety surveillance, COVID-19, adverse events

2.

Structure and Governance of Contractual Relations in Bulgarian Agriculture (Структура и управление на договорните отношения в селското стопанство на България)

Number of pages: 189 Posted: 01 Aug 2024
Institute of Agricultural Economics, Institute of Agricultural Economics, Independent, Agricultural Academy - Sofia, Bulgaria, Acumen, LLC, Standing Committee for Professional Standards and By-Laws of the Bulgarian Psychiatric Association and Institute of Agricultural Economics, Sofia
Downloads 61 (961,006)

Abstract:

Loading...

3.

Post-Authorization Safety Surveillance of Ad.26.CoV2.S Vaccine: Reports to the Vaccine Adverse Event Reporting System and v-Safe, February 2021-February 2022

Number of pages: 43 Posted: 12 Apr 2023
Government of the United States of America - Office of Biostatistics and Epidemiology, Centers for Disease Control and Prevention, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Acumen, LLC and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 51 (1,063,489)

Abstract:

Loading...

Ad.26.COV2.S COVID-19 vaccine, Coronavirus, SARS-CoV-2, adverse event, VAERS, v-safe

4.

Thrombocytopenia after Ad.26.COV2.S COVID-19 Vaccine: Reports to the Vaccine Adverse Event Reporting System

Number of pages: 16 Posted: 06 Apr 2022
Emily Jane Woo and Rositsa Dimova
Government of the United States of America - Office of Biostatistics and Epidemiology and Acumen, LLC
Downloads 42 (1,170,409)

Abstract:

Loading...

thrombocytopenia, VAERS, Ad.26.COV2.S COVID-19 vaccine, coronavirus, SARS-CoV2